Cargando…
Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?
The contribution of positron emission tomography/computed tomography (PET/CT) with 18F-fludeoxyglucose (FDG) in evaluating ovarian cancer recurrence even after a prolonged disease-free interval, and in therapy response is well-described. Calcifications observed in CT, although usually attributed to...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096626/ https://www.ncbi.nlm.nih.gov/pubmed/27277326 http://dx.doi.org/10.4274/mirt.22932 |
_version_ | 1782465497468502016 |
---|---|
author | Nikaki, Alexandra Alexopoulos, Athanasios Vlachou, Fani Filippi, Vasiliki Andreou, Ioannis Rapti, Vasiliki Gogos, Konstantinos Dalianis, Konstantinos Efthymiadou, Roxani Prassopoulos, Vassilios |
author_facet | Nikaki, Alexandra Alexopoulos, Athanasios Vlachou, Fani Filippi, Vasiliki Andreou, Ioannis Rapti, Vasiliki Gogos, Konstantinos Dalianis, Konstantinos Efthymiadou, Roxani Prassopoulos, Vassilios |
author_sort | Nikaki, Alexandra |
collection | PubMed |
description | The contribution of positron emission tomography/computed tomography (PET/CT) with 18F-fludeoxyglucose (FDG) in evaluating ovarian cancer recurrence even after a prolonged disease-free interval, and in therapy response is well-described. Calcifications observed in CT, although usually attributed to benign conditions, may actually represent active disease. Such an example of calcified formations is psammoma bodies. We present a case of 56-y. o. patient with ovarian cancer relapse at the supraclavicular area 18 years after complete response and disease-free interval. The patient received chemotherapy and underwent 18F-FDG-PET/CT for the evaluation of treatment response. Both CT corrected and uncorrected PET images showed hypermetabolism in the massively calcified lymph nodes in the neck, mediastinum, axilla and abdomen, indicative of active residual disease. |
format | Online Article Text |
id | pubmed-5096626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-50966262016-11-14 Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation? Nikaki, Alexandra Alexopoulos, Athanasios Vlachou, Fani Filippi, Vasiliki Andreou, Ioannis Rapti, Vasiliki Gogos, Konstantinos Dalianis, Konstantinos Efthymiadou, Roxani Prassopoulos, Vassilios Mol Imaging Radionucl Ther Case Report The contribution of positron emission tomography/computed tomography (PET/CT) with 18F-fludeoxyglucose (FDG) in evaluating ovarian cancer recurrence even after a prolonged disease-free interval, and in therapy response is well-described. Calcifications observed in CT, although usually attributed to benign conditions, may actually represent active disease. Such an example of calcified formations is psammoma bodies. We present a case of 56-y. o. patient with ovarian cancer relapse at the supraclavicular area 18 years after complete response and disease-free interval. The patient received chemotherapy and underwent 18F-FDG-PET/CT for the evaluation of treatment response. Both CT corrected and uncorrected PET images showed hypermetabolism in the massively calcified lymph nodes in the neck, mediastinum, axilla and abdomen, indicative of active residual disease. Galenos Publishing 2016-06 2016-06-06 /pmc/articles/PMC5096626/ /pubmed/27277326 http://dx.doi.org/10.4274/mirt.22932 Text en © Molecular Imaging and Radionuclide Therapy, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Nikaki, Alexandra Alexopoulos, Athanasios Vlachou, Fani Filippi, Vasiliki Andreou, Ioannis Rapti, Vasiliki Gogos, Konstantinos Dalianis, Konstantinos Efthymiadou, Roxani Prassopoulos, Vassilios Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation? |
title | Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation? |
title_full | Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation? |
title_fullStr | Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation? |
title_full_unstemmed | Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation? |
title_short | Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation? |
title_sort | hypermetabolic calcified lymph nodes on 18fludeoxyglucose-positron emission tomography/computed tomography in a case of treated ovarian cancer recurrence: residual disease or benign formation? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096626/ https://www.ncbi.nlm.nih.gov/pubmed/27277326 http://dx.doi.org/10.4274/mirt.22932 |
work_keys_str_mv | AT nikakialexandra hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation AT alexopoulosathanasios hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation AT vlachoufani hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation AT filippivasiliki hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation AT andreouioannis hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation AT raptivasiliki hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation AT gogoskonstantinos hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation AT dalianiskonstantinos hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation AT efthymiadouroxani hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation AT prassopoulosvassilios hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation |